ストックスクリーナーアプリを入手
25.16
2.89%
0.7078
前日終値:
$24.46
開ける：
$24.8
24時間の取引高:
18,320
Relative Volume:
1.25
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.64%
1か月 パフォーマンス:
+2.90%
6か月 パフォーマンス:
-13.08%
1年 パフォーマンス:
-2.56%
1日の値動き範囲:
$24.76
$25.18
1週間の範囲:
$24.37
$25.18
52週間の値動き範囲:
$23.97
$30.11
Tema Oncology Etf Stock (CANC) Company Profile
CANC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
25.16 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
299.14 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
603.05 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
605.70 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
252.64 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
524.80 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf (CANC) 最新ニュース
(CANC) Trading Report - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World
How To Trade (CANC) - Stock Traders Daily
Trading (CANC) With Integrated Risk Controls - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Shares Sold by Jane Street Group LLC - Defense World
Reshoring ETF Gets Boost From Trump Trade - etf.com
Long Term Trading Analysis for (CANC) - Stock Traders Daily
Tema's New VOLT ETF Sparked by AI Revolution - etf.com
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
(CANC) Investment Analysis - Stock Traders Daily
Pacer Data and Digital Revolution ETF (TRFK) Institutional Ownership 2024 - MarketBeat
(CANC) Technical Pivots with Risk Controls - Stock Traders Daily
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
The 5 Best Biotech ETFs of 2024 - TradingView
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
(CANC) Trading Advice - Stock Traders Daily
Thrivent Financial for Lutherans Invests $8.62 Million in Tema Oncology ETF (NASDAQ:CANC) - Defense World
National Bankshares Cuts Lucero Energy (CVE:LOU) Price Target to C$0.75 - Defense World
(CANC) Technical Data - Stock Traders Daily
Where are the Opportunities in (CANC) - Stock Traders Daily
Tema Oncology ETF (NASDAQ:CANC) Sees Large Decrease in Short Interest - Defense World
When the Price of (CANC) Talks, People Listen - Stock Traders Daily
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - Opto RoW
9 Best Biotech ETFs for 2024 - MSN
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
11 Best Biotech ETFs To Buy - Yahoo Finance
Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Yahoo Finance
Viking Therapeutics' weight-loss tablet shows promise in small study - ETHealthWorld
Is Gilead's 10% Crash — Resulting In A Failed Breakout — An Overreaction? - Investor's Business Daily
Sanofi CEO under pressure to woo investors after spending shock - Reuters.com
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters.com
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews
How BlackRock’s Rick Rieder is steering his active fixed-income ETF as bond funds struggle - MarketWatch
This Week in ETFs: 2 Funds Launch From Tema - ETFdb.com
Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties - Business Wire
Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire
Tema, Backed by Index, Accel and Zinal, Expands Access to Innovative Investment Themes Through Launch of Active ETF Platform - Business Wire
Ukroboronprom to Repair Captured Russian Tanks for Use by Ukrainian Army - Defense World
Getting in on global luxury - ETF Strategy
Biotechnology ETF List - ETFdb.com
Tema Oncology Etf (CANC) 財務データ
Tema Oncology Etf (CANC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.26%
大文字化:
|
ボリューム (24 時間):